Gene conversion as a source of nucleotide diversity in Plasmodium falciparum

Molecular Biology and Evolution

Volumn 20, Issue 5, 2003, Pages 726-734

  Nielsen, Kaare M ^a,b   Kasper, Jacob ^a   Choi, Mehee ^a   Bedford, Trevor ^a   Kristiansen, Kurt ^b   Wirth, Dyann F ^c   Volkman, Sarah K ^c   Lozovsky, Elena R ^a   Hartl, Daniel L ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF TROMSØ   (Norway)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Falcipain; Gene conversion; Paralogs; Plasmodium falciparum; Polymorphisms

Indexed keywords

DNA; FALCIPAIN 2A; FALCIPAIN 2B; NUCLEOTIDE; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVE SITE; GENE CONVERSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; MOLECULAR EVOLUTION; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BASE SEQUENCE; CLUSTER ANALYSIS; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; EVOLUTION, MOLECULAR; GENE CONVERSION; GENES, DUPLICATE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; VARIATION (GENETICS);

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0038709266     PISSN: 07374038     EISSN: None     Source Type: Journal    
DOI: 10.1093/molbev/msg076     Document Type: Article

References (35)

1. Abagyan, R., M. Totrov, and D. Kuznetsov. 1994. ICM: a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15:488-506.
2. Banerjee, D., P. Mayer-Kuckuk, G. Capiaux, T. Budak-Alpdogan, R. Gorlick, and J. R. Bertino. 2002. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta 1587:164-173.
3. Dua, M., P. Raphael, P. S. Sijwali, P. J. Rosenthal, and M. Hanspal. 2001. Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol. Biochem. Parasitol. 116:95-99.
4. Efron, B., and C. Stein. 1981. The jackknife estimate of variance. Ann. Stat. 9:586-596.
5. Engel, J. C., P. S. Doyle, I. Hsieh, and J. H. A. Mckerrow. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734.
6. Francis, S., I. Y. Gluzman, A. Oksman, D. Banerjee, and D. E. Goldberg. 1996. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol. Biochem. Parasitol. 83:189-200.
7. Francis, S. E., D. J. Sullivan, and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
8. Hanspal, M. 2000. cDNA cloning of a novel cysteine protease of Plasmodium falciparum. Biochim. Biophys. Acta 1493:242-245.
9. Hartl, D. L., S. K. Volkman, K. M. Nielsen, A. E. Barry, K. P. Day, D. F. Wirth, and E. A. Winzeler. 2002. The paradoxical population genetics of Plasmodium falciparum. Trends Parasit. 18:266-272.
10. Hughes, A. L. 1999. Adaptive evolution of genes and genomes. Oxford University Press, New York.
11. Hughes, A. L., and F. Verra. 2001. Very large long-term effective population size in the virulent human malaria parasite Plasmodium falciparum. Proc. R. Soc. London Ser. B Biol. Sci. 268:1855-1860.
12. Innan, H. 2002. A method for estimating the mutation, gene conversion and recombination parameters in small multigene families. Genetics 161:865-872.
13. Joachimiak, M. P., C. Chang, P. J. Rosenthal, and F. E. Cohen. 2001. The impact of whole genome sequence data on drug discovery: a malaria case study. Mol. Med. 7:698-710.
14. Jongwutiwes, S., C. Putaporntip, R. Friedman, and A. L. Hughes. 2002. The extent of nucleotide polymorphism is highly variable across a 3-kb region on Plasmodium falciparum chromosome 2. Mol. Biol. Evol. 19:1585-1590.
15. Lederberg, J. 2000. Infectious history. Science 288:287-293.
16. Mu, J., J. Duan, K. D. Makova, D. A. Joy, C. Q. Huynh, O. H. Branch, W.-H. Li, and X.-Z. Su. 2002. Chromosome-wide SNPs reveal an ancient origin for Plasmodium falciparum. Nature 418:323-326.
17. Olsen, J. E., G. K. Lee, A. Semenov, and P. J. Rosenthal. 1999. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg. Med. Chem. 7:633-638.
18. Pearlman, D. A., D. A. Case, J. W. Caldwell, W. S. Ross, T. E. Cheatham, S. Debolt, D. Ferguson, G. Seibel, and P. Kollman. 1995. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Phys. Comm. 91:1-41.
19. Phillips, R. S. 2001. Current status of malaria and potential for control. Clin. Microbiol. Rev. 14:208 ff inter alia.
20. Rich, S. M., M. C. Licht, R. R. Hudson, and F. J. Ayala. 1998. Malaria's Eve: evidence of a recent population bottleneck throughout the world population of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 95:4425-4430.
21. Rosenthal, P. J., G. K. Lee, and R. E. Smith. 1993. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Invest. 91:1052-1056.
22. Rosenthal, P. J., J. H. Mckerrow, M. Aikawa, H. Nagasawa, and J. H. Leech. 1988. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Invest. 82:1560-1566.
23. Rosenthal, P. J., W. S. Wollish, J. T. Palmer, and D. Rasnick. 1991. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J. Clin. Invest. 88:1467-1472.
24. Salas, F., J. Fichmann, G. K. Lee, M. D. Scott, and P. J. Rosenthal. 1995. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect. Immun. 63:2120-2125.
25. Semenov, A., J. E. Olsen, and P. J. Rosenthal. 1998. Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob. Agents Chemother. 42:2254-2258.
26. Shenai, B. R., P. S. Sijwali, A. Singh, and P. J. Rosenthal. 2000. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 275:29000-29010.
27. Sijwali, P. S., B. R. Shenai, J. Gut, A. Singh, and P. J. Rosenthal. 2001. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 360:481-489.
28. Sijwali, P. S., B. R. Shenai, and P. J. Rosenthal. 2002. Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain. J. Biol. Chem. 277:14910-14915.
29. Singh, A., and P. J. Rosenthal. 2001. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 45:949-951.
30. Somoza, J. R., H. J. Zhan, K. K. Bowman, L. Yu, K. D. Mortara, J. T. Palmer, J. M. Clark, and M. E. McGrath. 2000. Crystal structure of human cathepsin V. Biochemistry 39:12543-12551.
31. Su, X.-Z., M. T. Ferdig, Y. Huang, C. Q. Huynh, A. Liu, J. You, J. C. Wootten, and T. E. Wellems. 1999. A genetic map and recombination parameters of the human malaria parasite Plasmodium falcipirum. Science 286:1351-1353.
32. The Plasmodium Genome Database Collaborative. 2001. PlasmoDB: an integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data. The Plasmodium genome resource. Nucleic Acids Res. 29:66-69.
33. Verra, F., and A. L. Hughes. 2000. Evidence for ancient balanced polymorphism at the Apical Membrane Antigen-1 (AMA-1) locus of Plasmodium falciparum. Mol. Biochem. Parasitol. 105:149-153.
34. Volkman, S. K., A. E. Barry, E. J. Lyons, K. M. Nielsen, S. M. Thomas, M. Choi, S. S. Thakore, K. P. Day, D. F. Wirth, and D. L. Hartl. 2001. Recent origin of Plasmodium falciparum from a single progenitor. Science 293:482-484.
35. World Health Organization. 2000. WHO Expert Committee on Malaria. Twentieth report. 2000.